Main content
Bittersweet Medicine
A cutting-edge treatment turning a terminal diagnosis into hope for a healthy life.
A toddler with a rare and devastating inherited condition has become the first child to be treated in the UK with a lifesaving gene therapy. The drug, called Libmeldy, is the most expensive medicine in Europe, costing nearly three million pounds ($3.48m) per patient. For the family it is bittersweet as only one of the two children can be saved. The Ä¢¹½¶ÌÊÓÆµ's medical editor Fergus Walsh has followed the treatment at Royal Manchester Children's Hospital over several months and has this exclusive report.
Last on
Thu 23 Feb 2023
10:30GMT
Ä¢¹½¶ÌÊÓÆµ News except UK & UK HD
Credit
| Role | Contributor |
|---|---|
| Presenter | Fergus Walsh |
Broadcasts
- Sat 18 Feb 2023 12:30GMTÄ¢¹½¶ÌÊÓÆµ News except UK & UK HD
- Sun 19 Feb 2023 00:30GMTÄ¢¹½¶ÌÊÓÆµ News except UK & UK HD
- Sun 19 Feb 2023 07:30GMTÄ¢¹½¶ÌÊÓÆµ News except UK & UK HD
- Sun 19 Feb 2023 19:30GMTÄ¢¹½¶ÌÊÓÆµ News except UK & UK HD
- Thu 23 Feb 2023 10:30GMTÄ¢¹½¶ÌÊÓÆµ News except UK & UK HD